Previous Close | 1.2900 |
Open | 1.3100 |
Bid | 1.2100 x 100 |
Ask | 1.3400 x 100 |
Day's Range | 1.2600 - 1.3100 |
52 Week Range | 0.9400 - 4.2200 |
Volume | |
Avg. Volume | 604,006 |
Market Cap | 33.42M |
Beta (5Y Monthly) | 0.33 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.4700 |
Earnings Date | Jul 05, 2024 - Jul 09, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 6.94 |
VICTORIA, BC / ACCESSWIRE/ April 12, 2024 / InterSystems, a creative data technology provider dedicated to helping customers solve their most critical scalability, interoperability and speed challenges partnered with ImmunoPrecise Antibodies (NASDAQ:IPA) ...
VICTORIA, British Columbia, March 28, 2024--IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the "Company" or "IPA") (NASDAQ: IPA), InterSystems, a creative data technology provider dedicated to helping customers solve their most critical scalability, interoperability, and speed challenges, together with ImmunoPrecise Antibodies Ltd. (IPA) (NASDAQ: IPA), an artificial intelligence-driven biotherapeutic research and technology company, are thrilled to announce a landmark collaboration. This collaboration int
VICTORIA, British Columbia, March 20, 2024--IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the "Company" or "IPA") (NASDAQ: IPA), an artificial intelligence-driven biotherapeutic research and technology company, today announced that it has acquired the LSA® instrument platform from Carterra®, a leading provider of high-throughput large and small molecule screening and characterization solutions. This instrument allows for high throughput surface plasmon resonance-based antibody characterizations thereby s